LLY

1,009.7

-2.27%↓

JNJ

242.53

-0.95%↓

ABBV

223.88

-1.59%↓

NVS

165.21

-1.51%↓

MRK

119.49

-2.57%↓

LLY

1,009.7

-2.27%↓

JNJ

242.53

-0.95%↓

ABBV

223.88

-1.59%↓

NVS

165.21

-1.51%↓

MRK

119.49

-2.57%↓

LLY

1,009.7

-2.27%↓

JNJ

242.53

-0.95%↓

ABBV

223.88

-1.59%↓

NVS

165.21

-1.51%↓

MRK

119.49

-2.57%↓

LLY

1,009.7

-2.27%↓

JNJ

242.53

-0.95%↓

ABBV

223.88

-1.59%↓

NVS

165.21

-1.51%↓

MRK

119.49

-2.57%↓

LLY

1,009.7

-2.27%↓

JNJ

242.53

-0.95%↓

ABBV

223.88

-1.59%↓

NVS

165.21

-1.51%↓

MRK

119.49

-2.57%↓

Home・Aandelen Lijst・Cronos Group Inc

Cronos Group Inc

Open

SectorGezondheidszorg

2.66 -2.92

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.5300000000000002

Max

2.77

Belangrijke statistieken
By Trading Economics
Inkomsten	67M 28M
Verkoop	-7.9M 36M
K/W Sectorgemiddelde	24 108.767
Winstmarge	77.936
Werknemers	459
EBITDA	66M 31M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+5.84% upside

Dividenden
By Dow Jones
Volgende Winsten	26 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	38M 1B
Vorige openingsprijs	5.58
Vorige sluitingsprijs	2.66

Nieuwssentiment

By Acuity

100%

337 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

1.84 / N/A Steun & Weerstand

Cronos Group Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 feb 2026, 23:25 UTC

Populaire aandelen

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25 feb 2026, 23:15 UTC

Winsten

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25 feb 2026, 23:54 UTC

Marktinformatie

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25 feb 2026, 23:47 UTC

Winsten

Ferrovial 4Q Net EUR197M >FER.MC

25 feb 2026, 23:45 UTC

Winsten

Ferrovial 4Q Rev EUR2.72B >FER.MC

25 feb 2026, 23:42 UTC

Winsten

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25 feb 2026, 23:38 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Company's Business Operations Remain Normal >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com FY EPS CNY47.67 >TCOM

25 feb 2026, 23:06 UTC

Winsten

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25 feb 2026, 23:01 UTC

Winsten

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25 feb 2026, 23:00 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

25 feb 2026, 23:00 UTC

Marktinformatie

Winsten

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25 feb 2026, 22:56 UTC

Marktinformatie

Winsten

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25 feb 2026, 22:43 UTC

Winsten

Acquisities, Fusies, Overnames

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25 feb 2026, 22:40 UTC

Marktinformatie

Winsten

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25 feb 2026, 22:40 UTC

Winsten

Karoon Energy Says Search for New CFO Well Advanced

25 feb 2026, 22:39 UTC

Winsten

Karoon Energy Says CFO Ray Church to Leave Company

25 feb 2026, 22:39 UTC

Winsten

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25 feb 2026, 22:38 UTC

Winsten

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer Vergelijking

Prijswijziging

Cronos Group Inc Prognose

Koersdoel

By TipRanks

5.84% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 2.9 USD 5.84%

Hoogste 3.285 USD

Laagste 2.3 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cronos Group Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Cronos Group Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

1.84 / N/ASteun & Weerstand

Recent bullish events outweigh bearish events.

There are no events.

Sentiment

By Acuity

337 / 351 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Cronos Group Inc

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.